Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP523532.RAiNIdk-35nZFVW4T5q7zYP5wHr3CeBH-dULSfHPDToH4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP523532.RAiNIdk-35nZFVW4T5q7zYP5wHr3CeBH-dULSfHPDToH4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP523532.RAiNIdk-35nZFVW4T5q7zYP5wHr3CeBH-dULSfHPDToH4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP523532.RAiNIdk-35nZFVW4T5q7zYP5wHr3CeBH-dULSfHPDToH4130_provenance.
- NP523532.RAiNIdk-35nZFVW4T5q7zYP5wHr3CeBH-dULSfHPDToH4130_assertion description "[Western blot analysis of nuclear and cytoplasmic fractions identified Bok in both the nucleus and the cytoplasm of HEK 293T cells, HeLa cells, and breast cancer cells, and its nuclear concentration increased after treatment of those cells with leptomycin B, an inhibitor of the exportin Crm1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523532.RAiNIdk-35nZFVW4T5q7zYP5wHr3CeBH-dULSfHPDToH4130_provenance.
- NP523532.RAiNIdk-35nZFVW4T5q7zYP5wHr3CeBH-dULSfHPDToH4130_assertion evidence source_evidence_literature NP523532.RAiNIdk-35nZFVW4T5q7zYP5wHr3CeBH-dULSfHPDToH4130_provenance.
- NP523532.RAiNIdk-35nZFVW4T5q7zYP5wHr3CeBH-dULSfHPDToH4130_assertion SIO_000772 16302269 NP523532.RAiNIdk-35nZFVW4T5q7zYP5wHr3CeBH-dULSfHPDToH4130_provenance.
- NP523532.RAiNIdk-35nZFVW4T5q7zYP5wHr3CeBH-dULSfHPDToH4130_assertion wasDerivedFrom befree-2016 NP523532.RAiNIdk-35nZFVW4T5q7zYP5wHr3CeBH-dULSfHPDToH4130_provenance.
- NP523532.RAiNIdk-35nZFVW4T5q7zYP5wHr3CeBH-dULSfHPDToH4130_assertion wasGeneratedBy ECO_0000203 NP523532.RAiNIdk-35nZFVW4T5q7zYP5wHr3CeBH-dULSfHPDToH4130_provenance.
- befree-2016 importedOn "2016-02-19" NP523532.RAiNIdk-35nZFVW4T5q7zYP5wHr3CeBH-dULSfHPDToH4130_provenance.